Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age
- PMID: 21942727
- DOI: 10.3171/2011.8.JNS102114
Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age
Abstract
Object: The objective of this study was to analyze whether age influences the outcome of patients with glioblastoma and whether elderly patients with glioblastoma can tolerate the same aggressive treatment as younger patients.
Methods: Data from 361 consecutive patients with newly diagnosed cerebral glioblastoma (2000-2006) who underwent regular follow-up evaluation from initial diagnosis until death were prospectively entered into a database. Patients underwent resection (complete, subtotal, or partial) or biopsy, depending on tumor size, location, and Karnofsky Performance Scale score. Following surgery, all patients underwent adjuvant treatment consisting of radiotherapy, chemotherapy, or combined treatment. Patients older than 65 years of age were defined as elderly (146 total).
Results: Two hundred thirty-four patients underwent tumor resection (complete 26%, subtotal 29%, and partial 45%). One hundred twenty-seven underwent biopsy. Mean patient age was 61 years, and overall survival was 11.6 ± 12.1 months. The overall survival of elderly patients (9.1 ± 11.6 months) was significantly lower than that of younger patients (14.9 ± 16.7 months; p = 0.0001). Stratifying between resection or biopsy, age was a negative prognostic factor in patients undergoing biopsy (4.0 ± 7.1 vs 7.9 ± 8.7 months; p = 0.007), but not in patients undergoing tumor resection (13.0 ± 8.5 vs 13.3 ± 14.5 months; p = 0.86). Survival of elderly patients undergoing complete tumor resection was 17.7 ± 8.1 months.
Conclusions: In this series of patients with glioblastoma, age was a prognostic factor in patients undergoing biopsy, but not in patients undergoing resection. Tumor location and patient clinical status may prohibit extensive resection, but resection should not be withheld from patients only on the basis of age. In elderly patients with glioblastoma, undergoing resection to the extent feasible, followed by adjuvant therapies, is warranted.
Comment in
-
Glioblastoma in the elderly.J Neurosurg. 2012 Feb;116(2):355-6; discussion 356. doi: 10.3171/2011.6.JNS11982. Epub 2011 Sep 23. J Neurosurg. 2012. PMID: 21942728 No abstract available.
-
Letter to the Editor: Neoadjuvant chemotherapy to maximize glioblastoma resection in the elderly.J Neurosurg. 2015 Jul;123(1):295-6. doi: 10.3171/2012.7.JNS12342. Epub 2015 May 22. J Neurosurg. 2015. PMID: 26052627 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
